Malignant eccrine hidradenoma.
Cauthon DJ, Worthen T, Freed L, DeComas AM.
J Am Podiatr Med Assoc. 2013 Jul-Aug;103(4):333-6. doi: 10.7547/1030333.
Poroid hidradenoma: a benign lesion masking as a malignant breast tumor.
Liaqat H, Ammad Ud Din M, Malik D.
QJM. 2020 Oct 1;113(10):749-750. doi: 10.1093/qjmed/hcaa109.
[Hidradenoma papilliferum].
Elouarradi R, Hocar O.
Pan Afr Med J. 2014 Apr 14;17:274. doi: 10.11604/pamj.2014.17.274.4177. eCollection 2014.
Malignant clear cell hidradenoma of the upper lip.
Orlandi RR, Sercarz JA, Doberneck SA, Calcaterra TC.
Head Neck. 1994 Sep-Oct;16(5):443-9. doi: 10.1002/hed.2880160509.
Hidradenoma papilliferum.
MEEKER JH, NEUBECKER RD, HELWIG EB.
Am J Clin Pathol. 1962 Feb;37:182-95. doi: 10.1093/ajcp/37.2.182.
Lymph Node Involvement by a Clear Cell Nodular Hidradenoma-Like Tumor of Uncertain Malignant Potential.
Au B, Sidiropoulos KG, Ghazarian D, Sidiropoulos M.
Am J Dermatopathol. 2017 Dec;39(12):953-954. doi: 10.1097/DAD.0000000000000808.
Eccrine porocarcinoma.
Brown CW Jr, Dy LC.
Dermatol Ther. 2008 Nov-Dec;21(6):433-8. doi: 10.1111/j.1529-8019.2008.00243.x.
[Poroid hidradenoma].
Monteagudo B, Iglesias B, de la Torre C, Paredes C, Vázquez-Blanco M, Ginarte M, Labandeira J.
Actas Dermosifiliogr. 2005 Jul-Aug;96(6):398-9. doi: 10.1016/s0001-7310(05)73100-8.
Incidence, survival, and prognostic factors associated with malignant nodular hidradenoma in the United States.
Ugwu N, Cheraghlou S, Ko CJ, Cohen JM.
J Am Acad Dermatol. 2023 Apr;88(4):875-877. doi: 10.1016/j.jaad.2022.09.053. Epub 2022 Oct 11.
[Nodular hidradenoma].
Espejo Pérez I, Querol Gutiérrez JJ, Vílchez Márquez F.
Semergen. 2017 Sep;43(6):475-476. doi: 10.1016/j.semerg.2016.10.002. Epub 2016 Dec 16.
